Interleukin-7 and Chemokine (C-C motif) Ligand 19-expressing CD19-CAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-7 and Chemokine (C-C motif) Ligand 19-expressing CD19-CAR-T, covering 2019-04-26 to 2019-04-26. Get the full timeline:
Most recent: Clinical Trial Update: Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma. [Phase 2]